Rx PHARMASIST.CA
The Pharmasist newsletter

Stay current in
Canadian pharmacy.

Pharmacy news, practice updates and fresh perspectives—delivered to your inbox.

Keep your practice informed

  • Canadian pharmacy news

    Follow the developments shaping the profession.

  • Prescriber updates

    Stay informed about newly licensed Ontario physicians.

  • What's new on Pharmasist

    Explore new resources, tools and learning opportunities.

Free newsletter

A useful addition to your inbox.

We'll send a confirmation link first. Privacy policy

Amide-type local anesthetic

Lidocaine

Xylocaine

Dosage form
Tablet
Available strengths
0.5% (5 mg/mL), 1% (10 mg/mL), 2% (20 mg/mL) lidocaine hydrochloride; also available as 1% or 2% lidocaine hydrochloride with epinephrine 1:100, 000 or 1:200, 000
Drug class
Amide-type local anesthetic
Common brand
Xylocaine

Clinical overview. Lidocaine (brand name Xylocaine) is an amide-type local anesthetic injected to numb a specific area of the body for surgery, dental work, labour, or other procedures. It works by blocking nerve signals in the area where it is injected and is available with or without epinephrine to prolong its effect. It is administered only by trained healthcare professionals because of the risk of serious toxicity if it enters the bloodstream.

Indication

Common therapeutic uses

  • Lidocaine injection is used to produce local or regional anesthesia by infiltration, such as numbing an area of skin before a minor procedure.
  • It is used for peripheral nerve block techniques, including brachial plexus and intercostal nerve blocks, to numb a limb or region of the chest wall for surgery.
  • It is used for central neural techniques, including epidural and caudal blocks, to provide anesthesia or pain relief during surgery, labour, and delivery.
  • It is approved for use in adults and children 2 years of age and older; children under 2 require extra caution because of limited safety data.

Pregnancy

Risk assessment and monitoring considerations

  • There are no adequate, well-controlled studies of lidocaine in pregnant women, but a long history of use has not shown an increased risk of birth defects.
  • Care is advised during early pregnancy when the baby's organs are forming.
  • Lidocaine crosses the placenta rapidly, and epidural, paracervical, pudendal, or caudal blocks can cause varying degrees of toxicity in the mother, fetus, or newborn depending on the technique and dose used.
  • Epinephrine-containing lidocaine solutions may reduce blood flow to the uterus, particularly if accidentally injected into a maternal blood vessel.
  • Paracervical block can cause the fetal heart rate to slow or speed up, so continuous fetal heart rate monitoring is recommended when this technique is used.
  • Maternal low blood pressure can occur with regional anesthesia and is managed by positioning the patient on her side, raising her legs, and giving a blood-pressure-supporting medication if needed.

Breastfeeding

Infant exposure considerations

  • Lidocaine and its breakdown products pass into breast milk in small amounts that are not expected to pose a risk to a breastfeeding infant at normal therapeutic doses.
  • It is not known whether epinephrine passes into breast milk, but it is unlikely to affect a breastfed infant.

Geriatrics

Dosing and tolerability considerations

  • Older adults may be more sensitive to lidocaine's effects and typically require reduced doses.

Pediatrics

Use in children and adolescents

  • Children's doses are calculated by body weight, up to 5 mg/kg without epinephrine or up to 7 mg/kg with epinephrine.
  • Lidocaine should be used with caution in children younger than 2 years of age, since there is insufficient data on safety and effectiveness in this age group.

Dosage & Administration

Practical dosing and administration

  • Lidocaine dosing for local infiltration, nerve blocks, and epidural or caudal anesthesia is individualized based on the site and extent of the procedure, using the lowest volume and concentration that provides effective anesthesia.
  • For epidural and caudal blocks, a test dose is given first, with continuous heart monitoring, to help detect accidental injection into a blood vessel or the spinal fluid before the full dose is given.
  • The main dose is injected slowly or in small increments, with the healthcare professional aspirating (drawing back on the syringe) before and during injection to avoid injecting directly into a blood vessel.
  • Debilitated, elderly, or acutely ill patients, as well as those with sepsis, are given reduced doses because they are more sensitive to lidocaine's systemic effects.
  • When lidocaine is combined with other products containing lidocaine or related local anesthetics, the total combined dose from all sources must be kept within safe limits.

Overdose

Recognizing and responding to overdose

If overdose is suspected, seek emergency medical attention immediately or contact your regional Poison Control Centre without delay.

  • Early signs of excessive lidocaine levels include numbness around the mouth, a metallic taste, light-headedness, ringing in the ears, and blurred vision.
  • More severe toxicity can cause muscle twitching and tremors that progress to full-body convulsions.
  • Very high levels can cause loss of consciousness and stopped breathing.
  • Toxic levels can also depress the heart, causing a slow heart rate, low blood pressure, abnormal heart rhythms, and, in severe cases, cardiac arrest.
  • Management includes immediately stopping the injection, giving oxygen, and supporting the airway and breathing.
  • If convulsions occur, an intravenous anticonvulsant (such as a benzodiazepine or thiopental) is given, and cardiopulmonary resuscitation with continued oxygen support is provided if the heart stops.

Common side effects

Frequently reported tolerability concerns

  • Low blood pressure (hypotension) may occur.
  • High blood pressure (hypertension) may occur.
  • Nausea may occur.
  • Vomiting may occur.
  • Tingling or numbness (paresthesia) may occur.
  • Dizziness may occur.
  • A slow heart rate (bradycardia) may occur.

Serious side effects

Findings that may require urgent assessment

Serious side effects require immediate discussion with the prescriber or emergency care.

  • Signs of central nervous system toxicity, such as confusion, drowsiness, or ringing in the ears, may signal a developing overdose.
  • Convulsions may occur if lidocaine reaches high levels in the bloodstream.
  • Serious heart rhythm problems, including cardiac arrest, may occur.
  • Severe allergic reactions, including anaphylactic shock, may occur, though true allergy to amide anesthetics is rare.
  • Respiratory depression or complete stopping of breathing may occur with high doses or accidental injection into a blood vessel.
  • Nerve damage or spinal cord problems, including arachnoiditis or cauda equina syndrome, have been associated with regional anesthesia techniques.
  • A rare hypersensitivity reaction called Kounis syndrome, which can cause a heart attack-like presentation, has been reported.
  • Irreversible joint damage (chondrolysis) has been reported after unapproved continuous infusion of local anesthetics into a joint after surgery.
  • Seek urgent medical attention for chest pain, fainting, severe shortness of breath, an irregular or very slow heartbeat, or seizures after receiving lidocaine.

Use with caution

Situations requiring closer assessment

  • Use with caution in patients with epilepsy.
  • Use with caution in patients with impaired heart conduction, bradycardia, or other significant heart disease.
  • Use with caution in patients with severe shock.
  • Use with caution in patients with liver disease, since lidocaine is broken down by the liver and its effects may last longer.
  • Use with caution in patients with severe kidney impairment during long-term or repeated dosing, since metabolites may build up.
  • Use with caution in patients with a history of malignant hyperthermia; a standard management protocol should be available.
  • Use with caution in patients with acute porphyria, using it only when no safer alternative is available.
  • Use with caution in debilitated, elderly, or acutely ill patients and in those with sepsis, who require reduced doses.
  • Use with caution when injecting near the head and neck, including dental and eye procedures, because of the risk of accidental injection into an artery.

Contraindications

Situations where therapy may be inappropriate

  • Contraindicated in patients with known hypersensitivity to lidocaine or other amide-type local anesthetics.
  • Contraindicated in patients hypersensitive to sodium metabisulfite or citric acid, stabilizers used in epinephrine-containing solutions.
  • Contraindicated in patients hypersensitive to methylparaben, propylparaben, or their breakdown product PABA, preservatives used in multidose vials.
  • Preservative-containing lidocaine should not be used for epidural or spinal anesthesia, or any technique that could introduce it into the spinal fluid.
  • Preservative-containing lidocaine should not be injected into or around the eye.

Drug interactions

Clinically relevant combinations

  • Fluvoxamine, a strong inhibitor of the liver enzyme CYP1A2, can raise lidocaine blood levels during prolonged use.
  • Erythromycin and itraconazole, which inhibit the liver enzyme CYP3A4, can modestly reduce lidocaine clearance.
  • Propranolol and other beta-blockers can reduce lidocaine clearance and, when combined with epinephrine-containing lidocaine, can cause exaggerated blood pressure rises and slow heart rate.
  • Cimetidine can reduce lidocaine clearance, increasing the risk of toxicity with prolonged high-dose use.
  • Other local anesthetics or structurally related antiarrhythmic drugs, such as mexiletine, have additive toxic effects with lidocaine.
  • Class III antiarrhythmic drugs, such as amiodarone, may have additive cardiac effects with lidocaine and require close heart monitoring.
  • Ergot-type drugs used to contract the uterus should not be combined with epinephrine-containing lidocaine, since severe, persistent high blood pressure can result.
  • Monoamine oxidase inhibitors combined with epinephrine-containing lidocaine can cause severe, prolonged high blood pressure.
  • Tricyclic antidepressants, such as imipramine and amitriptyline-type drugs, combined with epinephrine-containing lidocaine can cause severe, prolonged high blood pressure.
  • Antipsychotics such as phenothiazines and butyrophenones can oppose the blood-vessel-narrowing effect of epinephrine, leading to low blood pressure and a fast heart rate.
  • Sedative medications can have an additive central nervous system depressant effect with lidocaine.
  • Inhaled general anesthetics such as halothane and enflurane increase the risk of serious heart rhythm disturbances when combined with epinephrine-containing lidocaine.

Food interactions

Meal-related administration

  • Lidocaine Parenteral Solutions are given by injection by a healthcare professional for a specific procedure, so there is no food or mealtime timing for a patient to follow, and the manufacturer states that interactions with food have not been established.

Time of administration

Practical scheduling

  • Lidocaine injection is administered by a healthcare professional at the time of the procedure requiring anesthesia, not on a fixed daily schedule.
  • Because it is given by injection rather than taken by mouth, there is no relationship to meals or time of day for the patient to manage.

Storage

Product handling

  • Store lidocaine solutions without epinephrine at controlled room temperature, between 15°C and 25°C.
  • Store lidocaine solutions containing epinephrine at the same temperature range and protect them from light and from freezing.
  • Single-dose vials and ampoules are for one use only and any unused portion should be discarded; multidose vials should not be used more than three days after first opening.

Patient take-away

Key counselling points for a quick closing summary

  • Lidocaine (Xylocaine) is a local anesthetic given by injection to numb a specific area of the body for procedures, surgery, or pain relief during labour, and it is administered only by trained healthcare professionals who monitor for rare but serious side effects.

References

Source material and product information

  1. Health Canada Product Monograph — Lidocaine

For professional reference. Confirm patient-specific decisions against the current approved product monograph and applicable clinical guidance.

Rejoining the server...

Rejoin failed... trying again in seconds.

Failed to rejoin.
Please retry or reload the page.

The session has been paused by the server.

Failed to resume the session.
Please retry or reload the page.